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Background: Malaria transmission in Latin America is typically characterized as hypo-endemic and unstable with ~170
million inhabitants at risk of malaria infection. Although Colombia has witnessed an important decrease in malaria
transmission, the disease remains a public health problem with an estimated ~10 million people currently living in
areas with malaria risk and ~61,000 cases reported in 2012. This study aimed to establish the malaria prevalence in
three endemic regions of Colombia to aid in designing new interventions for malaria elimination.
Methods: A cross-sectional survey was conducted in three regions of Colombia with different malaria epidemiological
profiles: Tierralta (Ta), Tumaco (Tu) and Buenaventura (Bv). The Annual Parasite Index (API) was 10.7, 6.9 and 3.1,
respectively. Participants were asked to respond to a sociodemographic questionnaire and then were bled to
determine the Duffy genotype and the prevalence of malaria infection by microscopy and quantitative real-time
PCR (qPCR).
Results: The study was conducted between October 2011 and January 2012. Eight sentinel sites with 1,169
subjects from 267 households were included. The overall prevalence of sub-microscopic infections measured by
thick blood smear (TBS) was 0.3% (n = 4) whereas by qPCR it was 9.7% (n = 113), with a greater proportion (13%)
in 40-50 years old individuals. Furthermore, different regions displayed different prevalence of sub-microscopic
infections: Bv 12%, Ta 15%, and Tu 4%. From these 113 samples (qPCR), 74% were positive for P. vivax and 22%
for P. falciparum, and 4% were mixed infections, which correlates to the overall parasite prevalence in Colombia.
This study showed that in the southern Pacific coast of Colombia (Bv and Tu), around 56% of the population
have a Duffy-negative genotype, compared to the northern region (Ta) where the percentage of Duffy-negative
genotype is around 3%.
Conclusions: Sub-microscopic infections are prevalent across different regions in Colombia, particularly in areas
with relatively low transmission intensity. The poor microscopy results suggest the need for more sensitive
diagnostic tools for detection of sub-microscopic infections. This study underscores the importance of conducting active
case surveillance to more accurately determine malaria incidence, and highlights the need for updating the
malaria guidelines to track and treat sub-microscopic malaria infections.Background
The burden of malaria has declined in recent years across
a number of countries as a result of increasing funding
and political commitment, implementation of new anti-
malarial treatments, better access to diagnostics, and
the extended use of insecticide-treated bed nets and in-
door residual spraying [1-3]. This reduction represents* Correspondence: sherrera@inmuno.org
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sustainability and the impact of routine prevention and
control measures, which should be adapted to the new
epidemiological settings. Since in low transmission set-
tings control interventions are likely to be less effective
[1]; as transmission declines national malaria control
programmes (NMCPs) must adapt and introduce ne-
cessary changes through the development and adoption
of novel strategies and methods. Operational research
contributes to this goal by providing evidence base for
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from asymptomatic to severe and fatal malaria. Continuous
exposure to Plasmodium parasites leads to clinical immun-
ity and asymptomatic carriers [4,5]. In addition, asymp-
tomatic cases provide a fundamental reservoir of parasites
contributing to malaria transmission. A better under-
standing of the role asymptomatic infections play in
transmission is essential for adapting and improving the
responsiveness of NMCPs and improving malaria elimin-
ation programmes [6-9].
Although microscopic diagnosis continues to be the
‘gold standard’ technique for malaria, including certification
of malaria elimination [10], molecular diagnostic methods
currently available would greatly contribute to assessing the
malaria burden in hypo-endemic regions. However, scaling
up molecular surveillance methods is still work in progress.
Rapid diagnostic tests (RDTs) that are easy to handle and
affordable significantly contribute to accelerate case de-
tection but they have equivalent sensitivity/specificity
to microscopy. Other techniques such as quantitative real
time polymerase chain reaction (qPCR) are more sensitive
[11,12], and more appropriate when malaria transmis-
sion approaches zero cases. Currently, the fact that these
asymptomatic infections are largely very low density and
not detected with the operative diagnosis methods (thick
smears and RDTs), represents a great hurdle for malaria
elimination [13,14]. In order to achieve successful elimin-
ation, detection of all parasite carriers by active case
detection and then treatment of all infections must be
considered to interrupt malaria transmission in endemic
areas. The identification and management of sub-microscopic
carriers has become a new and increasingly important
challenge for malaria control programmes [15]. The treat-
ment of all infections as part of routine surveillance strat-
egies has the potential to contribute significantly to the
reduction of malaria in endemic regions.
Although asymptomatic infections have not been ex-
tensively studied in Colombia, there is growing evidence
that sub-clinical infections are more common in the
region than previously thought [16,17]. This study aimed
to determine the malaria prevalence in three malaria-
endemic regions of Colombia.
Methods
Study sites
Three areas were selected in Colombia. Sentinel sites in
each of these areas were selected based on the annual
parasite index (API), accessibility and safety.
Tierralta is a municipality located in the Depart-
ment of Cordoba in the northwestern part of Colombia
with ~90,000 inhabitants composed of ~2% indigenous
groups and 44.4% rural population. The Annual Parasite
Index (API) in 2011 was 10.7. The predominant malaria
parasite species in this region is Plasmodium vivax(82.4%) followed by Plasmodium falciparum (17.4%)
and mixed malaria infections (0.2%) [18]. The selected
sentinel sites in this region were Tuis Tuis and La Unión.
Tumaco is located in the Department of Nariño in the
southwest of the country near the Ecuador border. It has
a population of ~187,084 inhabitants composed mainly
of Afro-descendants (88%). The API in 2011 was 6.9.
The predominant malaria parasite species in the region
is P. falciparum (79.2%) followed by P. vivax (20.8%) [18].
The sentinel sites selected in this region were Robles,
Candelillas and Bucheli.
Buenaventura is located on the Pacific coast of the Valle
Department in the west of Colombia, with ~350,000 inhab-
itants who are predominantly Afro-descendants (72.4%).
The API in 2011 was 3.1. The predominant malaria para-
site species in the region is P. vivax (85%) followed by
P. falciparum (15%) [18]. The sentinel sites selected in
this region were Punta Soldado, Zacarias and La Delfina.
Study design
The study was a cross-sectional survey in three malaria-
endemic regions of Colombia, which is one of the coun-
tries in the network of the Latin American Center for Re-
search on Malaria (CLAIM) established with the National
Institutes of Health (NIH) funding in 2010. The study was
conducted between October 2011 and January 2012 in
eight sentinel sites.
The study was developed in two steps: first, a population
census was performed with door-to-door visits and the help
of community leaders. The number of houses, people/
house, age, and sex were recorded. Based on this informa-
tion, a probabilistic sample was calculated for each sentinel
site with a confidence level of 95%, and error of 2% and an
estimated prevalence of 2%. Second, a set of houses was
randomly selected, and every person from the household
present at the moment of sampling answered a question-
naire regarding symptoms and epidemiologically relevant
information. Males and females of all ages were included.
No others visits were made.
Samples
Blood samples were collected by finger prick on filter
paper for malaria parasite DNA isolation and qPCR diag-
nosis. For Duffy genotype determination, a blood sample
of 500 μL was collected by venipuncture from every sub-
ject and stored in EDTA containing tubes. Samples were
handled as potential biohazards and all laboratory staff
strictly followed bio-safety standardized procedures.
Parasite detection
Thick blood smears
Approximately 100 μL of blood were collected by finger
prick and both thick and thin smears were prepared and
stained by Giemsa method for malaria diagnosis. Each
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copists, recording species and densities of sexual and
asexual forms. In positive films, parasite species were iden-
tified and density recorded as the number of parasites per
200 white blood cells (WBC). Two-hundred high-power
fields of the thick films examined at 1,000× magnification
were read before recording a negative result. Inter-observer
discordances were solved with the reading of a third micro-
scopist. Subjects were considered positive for malaria only
if two of the three readings were positive.
PCR methods
qPCR
Assays were performed as described previously [19,20]
with minor modifications. DNA was extracted from three
Ø 3 mm filter paper punches, equivalent to approximately
15 μL blood, using the PureLink Genomic DNA kit. DNA
was eluted in 60 μL of buffer. The amount of DNA in
each well was adjusted to be equivalent to 1 μL of whole
blood (4 μL of DNA). Standard P. falciparum and P. vivax
DNA positive and negative controls were used in each
batch of tests, including the extraction of both negative
and inhibition control. A sample was considered negative
if there was no increase in the fluorescent signal after a
minimum of 40 cycles. Parasitaemia quantification was
performed using a parasite-specific standard curve ob-
tained by diluting P. vivax and P. falciparum field iso-
lates to densities of 20000, 2000, 200, 20 and 2 p/μL,
spotted on filter papers and air dried. Each reaction plate
included a standard curve for parasite quantification.
Positive samples were confirmed by an independent DNA
extraction and a new round of qPCR by triplicates. Sam-
ples were considered positive with at least two positive
wells in the confirmation reaction.
Duffy genotype assessment
The sample size was calculated with a confidence level
of 95%, error of 5% and an estimated prevalence of the
Duffy negative genotype of 30% with a population census
of 5,603 for all the sentinel sites. DNA extraction was
performed from 200 μL of total blood samples collected
in EDTA tubes, using the PureLink Genomic DNA Mini
Kit (Invitrogen, USA) following manufacturer’s instructions.
The Duffy allele genotyping was performed by qPCR using
SYBR Green chemistry as described by Sousa et al. [21] pre-
viously standardized to screen volunteers for malaria clinical
trials at Caucaseco Scientific Research Center [22]. In each
plate, positive controls were included for genotypes FY*A/
FY*A, FY*A/FY*B, FY*A/FY*BES, and FY*BES/FY*BES.
Data analysis
Data entry
Study data were collected and managed using REDCap
electronic data capture tools hosted at Caucaseco ScientificResearch Center [23]. REDCap (Research Electronic Data
Capture) is a secure, web-based application designed to
support data capture for research studies, providing: 1) an
intuitive interface for validated data entry; 2) audit trails for
tracking data manipulation and export procedures; 3) auto-
mated export procedures for seamless data downloads
to common statistical packages; and, 4) procedures for
importing data from external sources. Information was
captured in the field in paper-based case report forms
(CRF). Data were digitized using REDCap (version 4.1)
and imported into MATLAB (version 2011b) for analysis.Data quality assurance
The data quality assurance (QA) procedure consisted of
setting a quality control (QC) sample of size q less than
the total number p of all case report forms (CRFs) for
each location. The maximum permissible error for this
study was set to 1%.Statistical analysis
Data analysis was performed using MATLAB (version
2011b). Using descriptive statistics, the general characteris-
tics of individuals admitted to the study were established.Ethics statement
This study was carried out in accordance with institu-
tional guidelines. The protocol was previously reviewed
and approved by the institutional review board (IRB)
of Caucaseco Scientific Research Center (CECIV, Cali-
Colombia). Written informed consent (IC) was obtained
from each volunteer at enrolment. Parents were asked to
consent for their child to take part in the study. Informa-
tion obtained from the participants was managed on prin-
ciples of confidentiality. Immediately after blood donation,
malaria-positive volunteers were provided with the anti-
malarial treatment recommended by the Colombian
Ministry of Health.Results
Demographic features
Between October 2011 and January 2012 a total of 1,169
subjects (57.7% female) were enrolled in three malaria-
endemic sites. A total of 272 volunteers were recruited
in Tierralta, 460 in Tumaco and 437 in Buenaventura
(Table 1). The mean age was 27 years (median 21 years;
interquartile range (IQR) 10-41 years) for all volunteers,
children ≤15 years of age (39.7%) were the main popula-
tion. Of the entire study population, 579 subjects (50.3%)
self-reported to have experienced previous lifetime malaria
episodes with a median of two previous episodes.
Table 1 Demographics of study populations
Buenaventura N = 437 Tierralta N = 272 Tumaco N = 460 Total N = 1,169
% [n] % [n] % [n] % [n]
Age (years) 0-4 12.7 [54] 11.3 [30] 4.4 [20] 9 [104]
5-14 26.8 [113] 33.8 [90] 239 [109] 27.3 [312]
15-30 27.3 [115] 24.8 [66] 29.4 [134] 27.6 [315]
>30 33.2 [140] 30.0 [80] 42.2 [192] 36.0 [412]
Sex Female 57.7 [252] 51.8 [141] 60.4 [278] 57.7 [674]
Previous episodes of malaria Yes 56.7 [242] 57.0 [154] 40.3 [183] 50.0 [579]
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falciparum infections
The overall malaria prevalence assessed in the three
study sites by thick blood smear (TBS) was 0.3% (4/
1,169). The prevalences in Tierralta and Tumaco were
0.4 (1/272) and 0.7% (3/460), respectively, whereas in
Buenaventura no positives slides were detected (Fig-
ure 1A). However, by using qPCR an overall prevalence
of 9.7% (113/1,169) was detected, over 26 times more
cases than those detected by TBS. The positivity rate
varied from 3 to 20%, indicating a large variability
among the sentinel sites (Table 2). Among the three
study regions, the highest positivity rate was in Tierralta
(15%; 40/272), followed by Tumaco (4%; 20/460) and
Buenaventura (12%; 53/437) (Figure 1B). The mean
parasitaemia (parasites/μL) in Tierralta determined by
qPCR was 56.74 (1-813), whereas in Buenaventura it was
60.7 (1-1,673) and in Tumaco it was 143.9 (8-1,021)
(Figure 1C). Among the qPCR-positive volunteers, 0.4%
(n = 5) presented symptoms, and the highest positivityFigure 1 Malaria prevalence in the study sites. (A) Prevalence by TBS; (B) p
stratification of qPCR-positive volunteers.rate was observed among the youngest people (0-15
years old) with a peak in habitants between 40-50 years
old (Figure 1D). The overall parasite distribution was
73.5% P. vivax, 22.1% P. falciparum and 4.4% mixed in-
fections. The P. vivax prevalence in Tierralta, Buenaven-
tura and Tumaco was 93, 66 and 50%, respectively
(Figure 2A). The prevalence in each sentinel site is
shown in Table 2 shows the number of positive qPCRs
for detection of either P. vivax and P. falciparum from
all samples or only asymptomatic individuals as indi-
cated in the two corresponding qPCR(+) columns; TBS
shows the number of positive samples with parasitaemia
detected by microscopy (thick blood smear); Samples
positive for the presence of P. vivax by qPCR are shown
in the indicated column; FY(+) indicates the % of people
presenting Duffy positive genotype.
Duffy genotype distribution
Of the 302 analysed samples, FY*BES/FY*BES was the
most frequent genotype (38.1%) in Colombia and FY*B/revalence by qPCR; (C) parasitaemia levels in the study areas; (D) age
Table 2 Parasite and Duffy genotype prevalences
Sites qPCR+ (%) qPCR+ (%) symptomatics TBS+ (%) P. vivax FY (+) (%)
Buenaventura Punta Soldado 23/145 (16%) 0/23 (0%) 0/145 (0%) 13/25 (57%) 11/35 (30%)
Zacarías 14/163 (9%) 2/14 (14%) 0/163 (0%) 11/14 (79%) 3/35 (9%)
La Delfina 16/129 (12%) 0/16 (0%) 0/129 (0%) 11/16 (69%) 26/36 (72%)
Total 53/437 (12%) 2/53 (4%) 0/437 (0%) 35/53 (66%) 47/106 (44%)
Tierralta Tuis Tuis 15/146 (10%) 1/15 (7%) 0/146 (0%) 14/15 (93%) 39/39 (100%)
La Unión 25/146 (20%) 0/25 (0%) 1/146 (1%) 24/25 (96%) 58/60 (97%)
Total 40/272 (15%) 1/40 (3%) 1/272 (0.4%) 38/40 (95%) 97/99 (98%)
Tumaco Robles 4/150 (3%) 0/4 (0%) 1/150 (1%) 1/4 (25%) 12/33 (36%)
Candelilla 12/160 (8%) 0/12 (0%) 2/160 (1%) 8/12 (67%) 14/35 (40%)
Bucheli 4/150 (3%) 2/4 (50%) 0/150 (0%) 1/4 (25%) 18/30 (60%)
Total 20/460 (4%) 2/20 (10%) 3/460 (0.6%) 10/20 (50%) 44/98 (46%)
113/1169 (10%) 5/113 (0.4%) 4/1169 (0.3%) 83/113 (73%) 118/303 (62%)
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population. However Duffy genotype distribution varied
considerably among the three malaria-endemic regions.
In Tierralta the most common genotype was FY*A/
FY*B with 29.3%, followed by FY*A/FY*A (24.2%),
FY*B/FY*BES (18.2%), FY*B/FY*B (15.2%), FY*A/FY*BES
(10.1%), and finally FY*BES/FY*BES with 3%. Contrasting
results were found in Tumaco and Buenaventura, which
are located on the Pacific coast, with a higher percent-
age of black African people than the Atlantic region. In
Tumaco the most common genotype was FY*BES/FY*BES
with 53.6%, followed by FY*A/FY*BES (21.6%), FY*B/
FY*B*ES (13.4%), FY*A/FY*B (5.2%), FY*A/FY*A (4.1%),
and finally FY*B/FY*B (2.1%). A similar pattern was found
en Buenaventura, being the most common FY*BES/FY*BES
with 56.6%, followed by FY*A/FY*BES (14.2%), FY*B/
FY*BES (10.4%), FY*A/FY*A (8.5%), FY*A/FY*B (7.5%),Figure 2 Parasite species and Duffy genotype distribution. (A) Parasite specie
(B) distribution of Duffy negative (red) and positive (blue) for each site withinand the least common FY*B/FY*B with 2.8%. Table 2
shows the Duffy prevalence by sentinel site. The para-
sites geographic distribution correlates with the Duffy
genotype distribution (Figure 2B).
Discussion
This study shows that in low transmissions settings of
Colombia there is a considerable amount of circulating
parasites at low parasitaemias which are not detected by
the current methods employed by the malaria control
programme. The prevalence of sub-microscopic infections
varies largely between 3 to 20%, with a higher rate in
regions where P. vivax is the predominant species. The
prevalence of malaria sub-microscopic infections in low-
transmission areas could be dependent on the detection
method used. This finding may explain the maintenance
or persistence of residual transmission foci due to thes distribution is shown for P. vivax (blue bars) and P. falciparum (red bars);
each region analysed is shown as a pie chart.
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sitaemia that are not regularly detected. Undetected asymp-
tomatic infections do not receive proper treatment,
contributing to maintaining the transmission cycle to
Anopheles vectors and therefore malaria transmission.
Additionally, our results demonstrate the effectiveness
of qPCR to detect these parasitaemias. The availability
of an efficient and effective technique for detecting these
infections would be a key factor for decision-making. Two
other studies in Colombia showed the presence of
asymptomatic malaria [16,17], however no estimation
of sub-microscopic infections was provided due to the
lack of a quantitative molecular method.
Accurate parasite prevalence determination is key for
monitoring malaria interventions. In this study, we pro-
vide first evidence showing submicroscopic parasitaemia
levels among apparently healthy volunteers in endemic
regions of Colombia. Several studies have reported de-
tection of infection by molecular methods. A study in
Rondônia, Brazil, showed that PCR was 6–7 times more
efficient than microscopy in detecting malaria infections
[24]. A previous study in Colombia using end point PCR
showed that molecular tools detected 61% more infections
than microscopy [16]. These results support the need
for implementing more sensitive diagnosis techniques in
order to detect these malaria reservoirs.
The Duffy glycoprotein antigen on red blood cells is a
receptor that binds the malaria parasite P. vivax, and red
blood cells that lack these antigens are resistant to invasion
by this parasite but can still be invaded by P. falciparum
[25]. In malaria-endemic regions, the Duffy genotype dis-
tribution affects the proportion of malaria infections due to
Duffy-negative population that are refractory to P. vivax
infections. On the southern Pacific coast of Colombia
(Buenaventura and Tumaco), the prevalence of the Duffy-
negative genotype was 56%, compared to the northern
region (Tierralta) where the corresponding percentage
was around 3%. On the other hand, the frequency of
Duffy-positive genotype was higher in Tierralta than in
Tumaco and Buenventura, these two areas being en-
demic for P. falciparum and Tierralta for P. vivax. The
parasite species distribution correlates with the Duffy
genotype prevalence, as P. vivax infection detected among
the Duffy positive individuals was five times higher than
P. falciparum. The distribution of the negative Duffy
genotype on the Pacific coast is consistent with the pre-
dominant Afro-descendants and the Mestizo population
migration patterns in Colombia. Furthermore, the very low
frequency of Duffy negative factor found in the North coast
population could be due to a higher percentage of inter-
breeding with indigenous populations and a low migration
pattern of Afro-descendants.
Because malaria prevalence officially reported by Pan
American Health Organization/World Health Organization(PAHO/WHO) is based on official country data, it is
significantly underestimated in the region [24,26,27]. Sub-
microscopic malaria infections have been increasingly
reported in malaria-endemic areas, especially in places
where malaria transmission intensities are relatively low
and where malaria elimination is being targeted [28].
Asymptomatic infections that remain undetected and
untreated contribute a major source of gametocytes for
local mosquito vectors, resulting in malaria transmission.
Whereas there is general agreement about sub-reporting
and other critical logistic aspects related to delivering
health services, the notion of sub-microscopic malaria
that results in undetectable transmission is not recognized
as of local or regional importance. Thus, biological com-
ponents of transmission need to be considered as a crucial
part of any research malaria agenda that aims to support
elimination. Additionally, targeting sub-microscopic
carriers will be a challenge for malaria control programmes.
Possible approaches to include sub-microscopic carriers in
treatment campaigns include mass screening and treatment
of all parasite carriers (MSAT) and mass treatment without
prior screening for parasitaemia, i.e., mass drug administra-
tion (MDA). MSAT depends on the availability of very
sensitive tools that could be used under field conditions.
A very low parasitaemia can be detected by molecular
methods such as qPCR; however, these techniques re-
quire considerable training and are restricted to reference
laboratories. Diagnostic tools, such as the Loop mediated
isothermal amplification (LAMP), which are capable of
detecting very low parasite densities (one parasite/μL) and
are reliable under field conditions could be important for
active case detection to accelerate malaria elimination
[29]. LAMP has been tested in Colombia under field
conditions with outstanding results [19]. However, cost-
effectiveness studies and proof of concept are needed in
order to include this technique in malaria control pro-
grammes. An alternative approach from this study is to
target MDA to those households with the highest preva-
lence of infection detected by molecular techniques. This
approach could increase the proportion of true positives
who would be treated [30].
Microscopy continues to be the gold standard method
both for malaria routine diagnosis and elimination [2],
however, the high occurrence of asymptomatic and sub-
microscopic infections only detectable by more sensitive
molecular techniques underscores the urgent need for
implementation of targeted surveillance strategies and
response activities in malaria elimination campaigns. These
findings have a deep impact on compliance with the goals
and in the evaluation of policies, plans, programmes, and
projects aimed to achieve malaria elimination in Colombia.
Indeed, in the Colombian Public Health Plan 2012-2021,
the malaria elimination in urban/peri-urban and hypo-
endemic settings was settled as a main goal. This political
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the new strategies presented in this work to improve
the operational strategies required for progress towards
malaria elimination.
Conclusion
The presence of sub-microscopic malaria infections in
different regions in Colombia shown here, especially in
areas of low transmission intensity, underscores the im-
portance of conducting active case surveillance to more
accurately determine malaria prevalence in endemic re-
gions, as well as to eliminate malaria reservoirs. There is
a need to use techniques more sensitive than microscopy-
based TBS for detection of these sub-microscopic infections.
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